Table 1.
Sociodemographic and clinical characteristics of the cohort.
Table 2.
Comparison of drug-susceptible and resistant TB patients and evaluation of associated risk factors.
Fig 1.
Repartition of drug-resistant M. tuberculosis clades in Haiti (n = 74).
Geographic repartition of DR-TB clades in partner study sites. Data are given for all patients with known spoligotypes. Pie chart size correlates with sample size in each site (Gheskio: n = 34. IMIS: n = 34. HUM: n = 3. HUJ: n = 2. HIC: n = 1).
Table 3.
Spoligotyping data of TB isolates in Haiti.
Table 4.
Description of DR-TB cases and characterization of genotypic and phenotypic drug-resistances by SIT.